You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 21, 2024

Details for Patent: 10,022,460


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,022,460
Title:Lipid-encapsulated gas microsphere compositions and related methods
Abstract: The invention provides, inter alia, improved lipid formulations used to generate lipid-encapsulated gas microspheres, and methods of their use.
Inventor(s): Robinson; Simon P. (Stow, MA), Siegler; Robert W. (Chelmsford, MA), Onthank; David C. (Groton, MA), Nguyen; Nhung Tuyet (Westford, MA)
Assignee: Lantheus Medical Imaging, Inc. (North Billerica, MA)
Application Number:15/602,534
Patent Claim Types:
see list of patent claims
 
Patent landscape, scope, and claims:

Detailed Analysis of the Scope and Claims of United States Patent 10,022,460

Introduction

United States Patent 10,022,460, titled "Lipid-encapsulated gas microsphere compositions and related methods," is a patent that covers innovative formulations and methods related to lipid-encapsulated gas microspheres. This analysis will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Patent Overview

Publication Details

  • Publication Number: US10,022,460B2
  • Authority: United States
  • Prior Art Date: The patent builds upon earlier research and developments in the field of lipid formulations and gas microspheres[4].

Scope of the Invention

Lipid-Encapsulated Gas Microspheres

The patent describes improved lipid formulations used to generate lipid-encapsulated gas microspheres. These microspheres are designed for various applications, including medical imaging and drug delivery. The invention focuses on enhancing the stability, efficacy, and safety of these microspheres.

Key Components

  • Lipids: The patent specifies various lipids, such as glycerol, propylene glycol, and other lipid components, which are crucial for the formulation of the microspheres[4].
  • Gas Fillings: The microspheres are filled with gases like octafluoropropane and tetrafluoromethane, which are commonly used in medical imaging applications[4].
  • Stabilizers and Diluting Agents: The patent includes the use of stabilizers and diluting agents to enhance the shelf life and performance of the microspheres.

Claims Analysis

Claim Structure

The patent contains multiple claims that define the scope of the invention. These claims can be categorized into several types:

Independent Claims

Independent claims define the broadest scope of the invention. For example, Claim 1 might describe the general composition of the lipid-encapsulated gas microspheres, including the types of lipids and gases used[4].

Dependent Claims

Dependent claims narrow down the scope by adding specific details or limitations to the independent claims. These could include specific ratios of lipid components, methods of preparation, or particular applications of the microspheres.

Claim Examples

  • Claim 1: This claim might describe a lipid-encapsulated gas microsphere composition comprising a lipid shell and a gas filling, such as octafluoropropane.
  • Claim 5: This claim could specify a method for preparing the microspheres, including steps for mixing the lipid components and encapsulating the gas.

Patent Landscape

Related Patents and Applications

The patent landscape for lipid-encapsulated gas microspheres is complex, with numerous patents and applications filed by various entities. Here are some key points:

Prior Art

The patent builds on prior art in the field, including earlier patents and publications related to lipid formulations and gas microspheres. The Common Citation Document (CCD) application, for instance, consolidates prior art cited by multiple patent offices, helping to identify relevant prior art[1].

Competing Patents

Other patents in the same field may cover similar or overlapping technologies. For example, patents related to medical imaging agents or drug delivery systems using microspheres could be relevant. Analyzing these patents using tools like the Claim Coverage Matrix can help identify gaps or opportunities in the existing patent landscape[3].

Global Patent Family

The Global Dossier service provided by the USPTO allows users to view the patent family for a specific application, including related applications filed at participating IP offices. This can help in understanding the global scope and protection of the invention[1].

Legal and Regulatory Considerations

Patent Validity and Enforcement

The patent is subject to the legal framework governing patents in the United States. This includes the presumption of validity under 35 U.S.C. § 282, and the possibility of inter partes review (IPR) or other post-grant proceedings to challenge the patent's validity[2].

Claim Construction

Claim construction is a critical aspect of patent litigation. The Federal Circuit has established that claim construction is a question of law, subject to de novo review on appeal. This means that the court's interpretation of the claims can significantly impact the scope of protection afforded by the patent[2].

Practical Applications and Future Directions

Medical Imaging

The lipid-encapsulated gas microspheres described in the patent are particularly useful in medical imaging, such as ultrasound imaging. These microspheres can enhance image contrast, allowing for better diagnostic outcomes.

Drug Delivery

The microspheres can also be used as drug delivery vehicles, encapsulating therapeutic agents and releasing them at targeted sites within the body.

Future Research and Development

The patent's scope concepts, as analyzed through tools like ClaimScape®, can help identify future design opportunities and areas where current coverage may be lacking. This can guide further research and development in optimizing the formulations and methods described in the patent[3].

Key Takeaways

  • Invention Scope: The patent covers improved lipid formulations and methods for generating lipid-encapsulated gas microspheres.
  • Claims Analysis: The patent includes independent and dependent claims that define the scope of the invention.
  • Patent Landscape: The patent is part of a broader landscape that includes prior art, competing patents, and global patent families.
  • Legal Considerations: The patent is subject to U.S. patent laws, including the presumption of validity and the possibility of post-grant proceedings.
  • Practical Applications: The microspheres have significant applications in medical imaging and drug delivery.

FAQs

What is the primary focus of United States Patent 10,022,460?

The primary focus of the patent is on improved lipid formulations and methods for generating lipid-encapsulated gas microspheres.

How do the claims in the patent define its scope?

The claims define the scope by specifying the composition of the microspheres, including the types of lipids and gases used, and the methods of preparation.

What are the key components of the lipid-encapsulated gas microspheres?

The key components include lipids such as glycerol and propylene glycol, and gases like octafluoropropane and tetrafluoromethane.

What are the practical applications of the invention described in the patent?

The microspheres are particularly useful in medical imaging and drug delivery.

How can the patent landscape be analyzed for this invention?

The patent landscape can be analyzed using tools like the Claim Coverage Matrix and the Global Dossier service to identify gaps, opportunities, and related patents.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. CAFC - VASCULAR SOLUTIONS LLC v. MEDTRONIC, INC.: https://cafc.uscourts.gov/opinions-orders/24-1398.OPINION.9-16-2024_2384927.pdf
  3. SLWIP - Patent Analytics: https://www.slwip.com/services/patent-analytics/
  4. Google Patents - US10022460B2: https://patents.google.com/patent/US10022460B2/en
  5. ACUS - U.S. Patent Small Claims Court: https://www.acus.gov/research-projects/us-patent-small-claims-court

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,022,460

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Lantheus Medcl DEFINITY RT perflutren INJECTABLE;INTRAVENOUS 021064-002 Nov 17, 2020 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,022,460

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2015374286 ⤷  Subscribe
Australia 2022201065 ⤷  Subscribe
Brazil 112017013787 ⤷  Subscribe
Canada 2972423 ⤷  Subscribe
China 107206111 ⤷  Subscribe
China 113289034 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.